IRIS
AQUARO, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.523
AS - Asia 4.696
EU - Europa 2.886
SA - Sud America 1.641
AF - Africa 289
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 9
Totale 16.056
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.282
SG - Singapore 2.194
BR - Brasile 1.275
UA - Ucraina 1.255
CN - Cina 808
VN - Vietnam 720
DE - Germania 677
SE - Svezia 268
TR - Turchia 200
IT - Italia 162
HK - Hong Kong 160
KR - Corea 155
CA - Canada 150
AR - Argentina 133
SN - Senegal 113
AT - Austria 96
FR - Francia 90
BD - Bangladesh 89
EC - Ecuador 88
RU - Federazione Russa 83
FI - Finlandia 80
IN - India 67
ID - Indonesia 56
ZA - Sudafrica 54
MX - Messico 49
GB - Regno Unito 42
IQ - Iraq 40
CO - Colombia 30
PY - Paraguay 27
VE - Venezuela 27
PK - Pakistan 25
CL - Cile 24
MA - Marocco 24
UZ - Uzbekistan 24
BE - Belgio 21
PL - Polonia 19
UY - Uruguay 19
KE - Kenya 18
ES - Italia 14
KZ - Kazakistan 14
ET - Etiopia 13
JP - Giappone 13
TN - Tunisia 13
AL - Albania 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
EG - Egitto 11
NL - Olanda 11
OM - Oman 11
RO - Romania 11
EU - Europa 10
JO - Giordania 10
LB - Libano 10
PE - Perù 10
AZ - Azerbaigian 9
HN - Honduras 9
PA - Panama 8
BO - Bolivia 7
CR - Costa Rica 7
MY - Malesia 7
NP - Nepal 7
PS - Palestinian Territory 7
SA - Arabia Saudita 7
AU - Australia 6
CZ - Repubblica Ceca 6
GE - Georgia 6
IL - Israele 6
LV - Lettonia 6
NG - Nigeria 6
BY - Bielorussia 5
IE - Irlanda 5
KG - Kirghizistan 5
NI - Nicaragua 5
AO - Angola 4
IR - Iran 4
JM - Giamaica 4
LK - Sri Lanka 4
QA - Qatar 4
SY - Repubblica araba siriana 4
TZ - Tanzania 4
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
DK - Danimarca 3
GA - Gabon 3
GR - Grecia 3
KW - Kuwait 3
MD - Moldavia 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CG - Congo 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
TG - Togo 2
TT - Trinidad e Tobago 2
Totale 16.029
Salva come PNG Salva come JPEG
Città #
Dallas 1.450
Jacksonville 866
Singapore 722
Chandler 607
Dearborn 447
Boardman 432
San Mateo 341
Ho Chi Minh City 278
Beijing 243
Lawrence 186
Roxbury 182
Izmir 180
Hanoi 158
Seoul 155
New York 150
Hefei 143
Ashburn 135
Shanghai 129
Des Moines 118
Dakar 113
Ottawa 113
São Paulo 113
Hong Kong 92
Cambridge 83
Helsinki 71
Ann Arbor 66
Wilmington 65
Vienna 64
Brooklyn 57
Grafing 51
Ogden 47
Los Angeles 45
Rio de Janeiro 42
Guayaquil 38
Haiphong 35
Inglewood 30
Brasília 27
Rende 26
Belo Horizonte 25
Quito 25
Seattle 25
Biên Hòa 23
Da Nang 23
Munich 22
Tashkent 22
Tianjin 22
Brussels 21
Johannesburg 21
Salvador 20
Guarulhos 19
Hải Dương 18
Porto Alegre 18
Rome 18
Nairobi 17
Toronto 17
Montevideo 16
Ribeirão Preto 16
San Francisco 16
Asunción 15
Dhaka 15
Moscow 15
Warsaw 15
Chicago 14
Council Bluffs 14
Curitiba 14
London 14
Santa Clara 14
Strasbourg 14
Boston 13
Buenos Aires 13
Bắc Ninh 13
Thái Nguyên 13
Ninh Bình 12
Tokyo 12
Baghdad 11
Bogotá 11
Campinas 11
Goiânia 11
Guangzhou 11
Phoenix 11
Pune 11
Amman 10
Amsterdam 10
Campo Grande 10
Can Tho 10
Cape Town 10
Manaus 10
Norwalk 10
Santo André 10
Wuhan 10
Betim 9
Charlotte 9
Columbus 9
Lima 9
Nanjing 9
The Dalles 9
Thái Bình 9
Addis Ababa 8
Almaty 8
Caracas 8
Totale 8.978
Salva come PNG Salva come JPEG
Nome #
1,2,3-triazole-TSAO analogues: Synthesis and anti-HIV activity 1.470
Carbazole Derivatives as Antiviral Agents: An Overview 175
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 150
Cachrys spp. from Southern Italy: Phytochemical Characterization and JAK/STAT Signaling Pathway Inhibition 141
Identification of chlorocarbazole derivatives as potential antiviral agents. 140
Progettazione, studio di docking molecolare e sintesi di nuove molecole capaci di interagire con il virus responsabile della SARS-COVID 19. 133
ANTIBACTERIAL AND ANTIVIRAL PHARMACEUTICAL COMPOSITION 129
Apoptosis in Human Astrocytic Cells Induced by HIV-Infected Macrophages 128
Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs. 127
Activity of masked 2’-3’-dideoxynucleoside-monophosphate derivatives against human immunodeficiency virus in resting macrophages 121
Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity 120
AZT treatment of HIV-1 infected macrophages prevents apoptosis and necrosis in human astrocytic cells 119
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: new evidence and future perspectives 119
Analisi mediante PCR dell’influenza di citochine sulla replicazione virale di HIV-1 e HSV-1 in macrofagi primari umani 116
Antiretrovirus activity of novel class of acyclic pyrimidine nucleoside phosphonates 115
Activity of GM-CSF and M-CSF upon Replication of HIV and Other DNA- and RNA-Viruses in Primary Macrophages 114
Anti-HIV activity of protease inhibitors in productively-infected macrophages and correlation with clinical outcome 114
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90. 114
Anti-HIV activity of nucleoside analogues in mononuclear cells. Workshop on Recent advances in modified nucleosides 113
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics 112
Anti-nerve Growth Factor Antibody Abrogates Macrophages-mediated HIV-1 Infection and Depletion of CD4+ T-lymphocytes in hu-SCID Mice 111
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies. 111
Anti-HIV efficacy in primary monocyte/macrphage by phosphorylated and phosphonated derivatives of nucleside analogues 110
Activity of masked 2’-3’-Dideoxynucleoside Monophosphate Derivatives Against Human Immunodeficiency Virus in Resting Macrophages 109
Anti-nerve growth factor Ab abrogates macrophage mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice 106
Acyclic nucleoside phosphonates: A new class of compounds with antiviral and immunomodulatory activity 100
Antiviral efficacy of inhibitors of HIV protease in chronically-infected macrophages 96
Antiviral activity of amprenavir in human macrophages acutely and chronically infected by HIV-1 95
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 94
Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic. 92
CARBAZOLE DERIVATIVES TARGETING HUMAN TOPOISOMERASES I AND ACTIN IN BREAST CANCER TREATMENT 90
Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus 90
Thidiazuron: New Trends and Future Perspectives to Fight Xylella fastidiosa in Olive Trees 88
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine [(R)-PMPA] and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine [(R)-PMPDAP] against Human Immunodeficiency Virus in Different Human Cell Systems 88
Glutathione inhibits HIV replication by acting at late stages of virus lifecycle 87
Understanding HIV compartments and reservoirs. 85
Factors affecting the anti-HIV and anti-HSV activity of nucleoside analogues in macrophages 85
Nerve growth factor in an autocrine factor essential for the survival of macrophages infected by human immunodeficiency virus 83
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives 83
Antiviral activity of nucleoside analogues in macrophages 82
Il macrofago e l’infezione da HIV. Ruolo delle cellule lungo sopravviventi nella patogenesi e nella terapia. 82
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 81
Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically-infected macrophages 81
Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir 80
Studio di fattori che influenzano l’attivita’ anti-HIV ed anti-HSV di analoghi nucleosidici nei monociti-macrofagi 79
The counter-current centrifugal elutriation (cee) as essential tool for purification of monocytes and the assessment of the activity of cytokines upon virus replication 79
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 77
Therapeutic strategies towards HIV-1 infection in macrophages 77
Modulazione dell’infezione da virus influenzale in macrofagi trattati con citochine 77
oxidative stress and HIV infection:target pathways for novel therapies? 76
Dinamica virale nei reservoirs. Infezioni da HIV: approfondimenti sul tema 76
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus 76
Influenza virus A (H5N1): a pandemic risk? 75
Attivita’ di farmaci inibitori del virus dell’immunodeficienza umana in macrofagi umani e correlazione con l’efficacia clinica 75
Phosphorylated and phosphonated derivatives of nucleoside analogues are more active against HIV in monocyte/macrophages than in lymphocytes 75
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 75
The Ongoing Impact of COVID-19 on Pediatric Obesity 74
Cyclosaligenil-2’,3’-didehydro-2’,3’ – dideoxythymidine Monophosphate: efficient Intracellular Delivery of d4TMP 74
Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages 74
Microbiological Characteristics and Physico-chemical Parameters of Fermented Milk Product Ergo-A Traditional Yogurt Product of Ethiopia 74
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 74
Le mutazioni osservate nei macrofagi primari umani dopo trattamento con farmaci inibitori della transcrittasi inversa non conferiscono resistenza 73
The Potent Inhibition of Human Immunodeficiency Virus and Herpes Simplex Virus Type 1 by 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA) in Primary Macrophages Is Determined by Drug Metabolism, Nucleotide Pools and Cytokines 73
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 72
Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist 72
Inhibition of HIV replication in primary macrophages by antiviral drugs: Modulation by cytokines and comparative efficacy in lymphocytes 72
M40401, a sod mimetic compound with a potent anti-HIV activity in macrophages, prevents apoptosis in astrocytes 72
TAK-779 blocca il corecettore CCR5 ed inibisce fortemente la replicazione di ceppi monocitotropi di HIV, in vitro ed in vivo 72
Development of resistance to anti-HIV drugs in primary macrophages 72
Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype. 71
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 71
Attività anti-HIV di differenti classi di farmaci antivirali di interesse clinico: valutazione in vitro dell’efficacia in monociti/macrofagi primari e linfociti 71
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies 71
S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation 71
Antiviral Profile of HIV Inhibitors in Macrophages: Implications for Therapy 70
Razionale della terapia dell’encefalopatia da HIV-1: inibizione della replicazione virale in macrofagi 70
Macrofagi infettati da HIV provocano in vitro morte cellulare per apoptosi in cellule astrocitarie 70
Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage 70
Are Nutraceuticals Effective in COVID‐19 and Post‐COVID Prevention and Treatment? 69
Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus 69
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages 69
Phylogenetic analysis of the surface proteins of influenza A (H5N1) viruses isolated in Asian and African populations 69
Different antiviral activity of anti-HIV drugs in primary monocyte/macrophage cells and in lymphocytes: modulation by M-CSF 69
Silver and Gold Complexes with NHC-Ligands Derived from Caffeine: Catalytic and Pharmacological Activity 69
NGF is an autocrine factor essential foe the survival of macrophages infected with HIV 68
GM-CSF and M-CSF modulate the replication of HIV and other viruses in primary macrophages by acting on different steps of virus lifecycle 68
The Treatment with the Fusion Inhibitor Enfuvirtide Influences the Appearance of Mutations in the HIV-1 Regulatory Protein Rev 68
Cytokines in HIV infection 68
Identification of Pinosylvin in Pinus nigra subsp. laricio: A Naturally Occurring Stilbenoid Suppressing LPS-Induced Expression of Pro-Inflammatory Cytokines and Mediators and Inhibiting the JAK/STAT Signaling Pathway 67
Impact of Cytochrome P450 Enzymes on the Phase I Metabolism of Drugs 67
NEUROAIDS: VIROLOGICAL ASPECTS OF HIV INFECTION 67
Enhancement of the replication of HIV and other viruses in primary macrophages treated with colony stimulating factors 67
Presence of 2’,5’-Bis-O-(tert-butyldimethilsylil)-3’-spiro-5”-(4”-amino-1”,2”-oxathiole-2”,2”-dioxide)(TSAO)-resistant virus strain in TSAO-inexperienced HIV patients 66
Macrofagi e neuro-AIDS 66
Dynamics of HIV replication in primary macrophages and modulation by antiviral drugs 66
Long lasting and efficient inhibition of HIV replicationn in Human primary macrophages by treatment with protease inhibitors 66
HIV-1-mediated apoptosis occurs in macrophages infected by X4, but not by R5 viruses 66
In vitro activity of inhibitors of late stages of the replication of HIV in chronically-infected macrophages 65
Caratterizzazione dell’efficacia antivirale di inibitori della proteasi di HIV in macrofagi cronicamente infettati, e correlazione con l’efficacia clinica 65
Factors released by HIV infected macrophages induce apoptosis of uninfected lymphocytes 65
Totale 10.058
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021773 0 0 0 0 0 186 10 193 28 186 6 164
2021/20221.552 18 165 4 112 139 61 12 405 34 9 201 392
2022/20231.536 224 110 51 182 155 134 2 221 236 47 112 62
2023/2024881 88 25 56 27 46 172 21 35 107 30 46 228
2024/20252.365 139 456 51 92 129 106 74 132 435 136 202 413
2025/20266.328 1.166 577 1.606 1.150 1.721 108 0 0 0 0 0 0
Totale 16.144